Current Measure Incubator Development and Testing Projects Include:

• Non-small cell lung cancer (NSCLC) biomarkers (PDF), which aims to develop and test two measures: 1) biomarker testing to inform treatment, and 2) turnaround time. This Measure Incubator project is supported by Genentech.
• Alzheimer’s Disease (PDF), which aims to develop and test one Alzheimer’s disease caregiver performance measure. This Measure Incubator project is supported by Genentech.
• Outcome measures for rheumatoid arthritis (RA), including a measure focused on treat-to-target approaches and a PRO-PM (PDF), made possible with support from Bristol-Myers Squibb.
• Outcome measures to assess survival rates for individuals with lung cancer and a lung cancer PRO-PM (PDF), made possible with support from Bristol-Myers Squibb.
• Outcome measures to assess survival rates for individuals with melanoma (PDF) made possible with support from Bristol-Myers Squibb.
• Food insecurity measure development and testing (PDF), which aims to develop and test three measures: 1) screening 2) appropriate clinical action and 3) change in food insecurity. This Measure Incubator project is supported by Humana.
• Work with AARP and OptumLabs to select novel measure development and/or testing proposals for AARP’s 2019 Quality Measures Innovation Grant program. Two awards were issued: (1) National Kidney Foundation, in collaboration with AMGA, National Committee for Quality Assurance, PCPI, and the University of California San Francisco, proposed a performance measure to evaluate kidney health in adults with diabetes mellitus; and, (2) Johns Hopkins Armstrong Institute for Patient Safety and Quality proposed to measure stroke misdiagnosis in hospital emergency rooms.

Current Measure Incubator Measure Concept Identification and Prioritization Strategy Sessions Include:

• The Measure Incubator does not have any ongoing strategy sessions at this time.

Completed Measure Incubator Projects Include:

• A collaboration with Integrated Health Association to develop and pilot a benchmarking framework (PDF) for California ACOs that could serve as a national model.
• Performance measures of serial body mass index and shared decision-making (PDF), with funding from NovoNordisk.
• Work with MN Community Measurement to develop and test a chronic obstructive pulmonary disease (COPD) PRO-PM (PDF). The Measure Incubator received funding from GlaxoSmithKline to support this project.
• Nonvalvular atrial fibrillation (NVAF)-related stroke prevention (PDF) strategy session, with financial support from Bristol Myers Squibb – Pfizer Alliance and Johnson & Johnson Health Care Systems, Inc (JJHCS). An Expert Panel identified a suite of measure concepts and prioritized measures focusing on screening for health literacy, extended cardiac monitoring following cryptogenic stroke, anticoagulation dosing, anticoagulation prescribing in primary care, shared decision making, and stroke outcome.
• Preventing C. difficile infections in the community (PDF) strategy session, with support from Pfizer Inc. An Expert Panel identified a suite of measure concepts and prioritized measures focusing on antibiotic stewardship, improving treatment, improving diagnosis and testing, and patient education/experience.
• Appropriate care and chronic disease management for Lupus (PDF) with support from Johnson & Johnson Health Care Systems, Inc (JJHCS). An Expert Panel identified a suite of measure concepts that focus on improving Lupus health outcomes and patient quality of life.
• Postoperative Delirium (POD) Measures (PDF), with financial support from Medtronic. An Expert Panel identified a suite of measure concepts focused on the prevention and mitigation of POD.
• Work with PatientsLikeMe®, with funding from the Robert Wood Johnson Foundation, to test a novel approach to gather broad patient input in developing PRO-PMs.
• Work with Pharmacy Quality Alliance (PQA) and National Health Council (NHC), with funding from Merck & Co., Inc., to create a rubric for assessing patient engagement in quality measurement (PDF).
• Initial development of a multiple sclerosis (MS) performance measure (PDF) focused on patient-reported outcomes in the clinical setting, with funding from Biogen. An Expert Panel recommended development of a performance measure assessing the use of an MS-specific PRO measure (PROM) in clinical care.
• Work with AARP and OptumLabs to select novel measure development and/or testing proposals for AARP’s 2017 Quality Measures Innovation Grant program. Two awards were issued: (1) PQA, in collaboration with the University of Maryland, proposed a patient safety and outcome measure for people with diabetes; and, (2) Tufts Medical Center, in collaboration with Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, proposed a patient safety measure for treating cancer patients.
• Hospice and palliative care person-centered measurement, funded by Compassus. An Expert Panel
  identified a roadmap for developing PRO-PMs for hospice and palliative care.
• Pain management in acute care settings, funded by Mallinckrodt. An Expert Panel identified measure
  concepts for pain management in the perioperative setting, including concepts focused on opioid use.
• Tools and measure concepts focused on surgical pain management, with support from
  Heron Therapeutics, Inc. An Expert Panel identified measure concepts that focus on pain management
  and prevention and management of opioid use disorder and adverse events.
• Social determinants of health, particularly food insecurity (PDF), with support from
  the Aetna Foundation. An Expert Panel identified a suite of measure concepts that focus on addressing food insecurity within the healthcare context.
• Patient-reported outcomes for advanced prostate cancer (PDF), with support from Johnson & Johnson
  Health Care Systems, Inc. (JJHCS). An Expert Panel identified a mix of patient- and caregiver-reported measures and process measures.
• Symptom control and opioid use in patients with inflammatory bowel disease (IBD) (PDF), with support from Johnson & Johnson Health Care Systems, Inc. (JJHCS). An Expert Panel identified measure concepts focus on integrating routine assessments of quality of life and patient engagement within clinical practice,
  evidence-based care, and inappropriate use of opioids.
• Timely and appropriate biomarker screening and treatment for common genetic mutations in non-small cell
  lung cancer (NSCLC) (PDF), with support from Genentech, Inc. An Expert Panel identified measure concepts that span the continuum of care—from biopsy through treatment—and assess the role of medical oncologists, pathologists, and laboratories in ensuring that patients receive evidence-based diagnosis and care.
• Early detection and patient- and caregiver-centered care for early-stage Alzheimer’s disease (PDF),
  with support from Genentech, Inc. An Expert Panel identified measure concepts focused on integrating
  routine screening for and assessment of cognitive impairment and caregiver engagement within
  clinical practice.
• Learning Collaborative: NQF’s Learning Collaborative is a forum of diverse stakeholder organizations that are united in their commitment to improve measure development. See previous work here.